KLK3 and prostate carcinoma: (36) constructed the Chinese Prostate Cancer Consortium Risk Calculator (CPCC-RC) based on PSA, age, prostate volume, fPSA-to-tPSA rate, and DRE for forecasting the initial prostate biopsy.